Schizophrenia Trial, Recruiting NCT06048172 Sponsor: Medicalschool Hamburg Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT06048172
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with a psychotic disorder or a mood disorder that includes psychotic symptoms (such as hallucinations or delusions), based on standard diagnostic guidelines
  • You have also been diagnosed with Post-Traumatic Stress Disorder (PTSD), confirmed by a specific assessment score
  • You are at least 18 years old
  • You have a good understanding of the German language
  • You are willing to be randomly assigned to a treatment group and to take part in therapy focused on past trauma

Who may not be able to join:

  • Your antipsychotic or antidepressant medication has been changed in the last 4 weeks
  • You are currently dependent on any substance (such as alcohol or drugs), not including nicotine or caffeine
  • You have an IQ of 70 or below
  • You are currently considered to be at acute (immediate) risk of suicide
  • You are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 00491733968992

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Medicalschool Hamburg
Registry
ClinicalTrials.gov
Start date
15 May 2023
Est. completion
17 May 2028

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

severity of PTSD symptoms; Remission of PTSD diagnosis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov